MORTARINO, MIMOSA
MORTARINO, MIMOSA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices
2023 I. Cutica, M. Mortarino, I. Garagiola, G. Pravettoni, F. Peyvandi
Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia
2023 I. Cutica, M. Mortarino, I. Garagiola, G. Pravettoni, F. Peyvandi
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers
2020 I. Garagiola, M. Mortarino, S.M. Siboni, M. Boscarino, M.E. Mancuso, M. Biganzoli, E. Santagostino, F. Peyvandi
Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity
2018 I. Donadon, J.H. Mcvey, I. Garagiola, A. Branchini, M. Mortarino, F. Peyvandi, F. Bernardi, M. Pinotti
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients : evidence for a founder effect
2016 I. Garagiola, S. Seregni, M. Mortarino, M.E. Mancuso, M.R. Fasulo, L.D. Notarangelo, F. Peyvandi
Reproductive care in human immunodeficiency virus serodiscordant couples with haemophilia
2013 I. Garagiola, M. Mortarino, A.E. Semprini, F. Peyvandi
Non-invasive tool for foetal sex determination in early gestational age
2011 M. Mortarino, I.M. Garagiola, L.A. Lotta, S.M. Siboni, A.E. Semprini, F. Peyvandi
Prenatal diagnosis and preimplantation genetic diagnosis : novel technologies and state of the art of PGD in different regions of the world
2011 F. Peyvandi, I.M. Garagiola, M. Mortarino
Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility
2010 G.C. Ghedini, V. Ciravolo, M. Tortoreto, S. Giuffre, F. Bianchi, M. Campiglio, M. Mortarino, M. Figini, A. Coliva, M.L. Carcangiu, M. Zambetti, T. Piazza, S. Ferrini, S. Menard, E. Tagliabue, S.M. Pupa